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ABSTRACT
Introduction An effective workforce is essential for 
optimal care of all forms of chronic diseases. The objective 
of this study was to assess workforce capacity for kidney 
failure (KF) care across world countries and regions.
Methods Data were collected from published online 
sources and a survey was administered online to key 
stakeholders. All country- level data were analysed by 
International Society of Nephrology region and World Bank 
income classification.
Results The general healthcare workforce varies by 
income level: high- income countries have more healthcare 
workers per 10 000 population (physicians: 30.3; nursing 
personnel: 79.2; pharmacists: 7.2; surgeons: 3.5) than 
low- income countries (physicians: 0.9; nursing personnel: 
5.0; pharmacists: 0.1; surgeons: 0.03). A total of 160 
countries responded to survey questions pertaining to 
the workforce for the management of patients with KF. 
The physicians primarily responsible for providing care to 
patients with KF are nephrologists in 92% of countries. 
Global nephrologist density is 10.0 per million population 
(pmp) and nephrology trainee density is 1.4 pmp. High- 
income countries reported the highest densities of 
nephrologists and nephrology trainees (23.2 pmp and 3.8 
pmp, respectively), whereas low- income countries reported 
the lowest densities (0.2 pmp and 0.1 pmp, respectively). 
Low- income countries were most likely to report shortages 
of all types of healthcare providers, including nephrologists, 
surgeons, radiologists and nurses.
Conclusions Results from this global survey demonstrate 
critical shortages in workforce capacity to care for patients 
with KF across world countries and regions. National and 
international policies will be required to build a workforce 
capacity that can effectively address the growing burden of 
KF and deliver optimal care.
INTRODUCTION
The global burden of chronic kidney disease 
(CKD) continues to rise, with a current prev-
alence estimated at 13.4%.1–3 Patients with 
kidney disease are notably complex, with 
recent studies showing that nephrologists 
rank highest compared with all other general 
and medical subspecialists with regard to 
patient complexity.4 The presence of CKD 
indicates a higher risk of adverse events for 
patients with diabetes, hypertension and 
cardiovascular disease.2 5 6 Furthermore, CKD 
is associated with increasing healthcare costs.5
The delivery of comprehensive kidney 
disease care, including risk factor modifica-
tion, kidney replacement therapy (dialysis 
and kidney transplantation), delivery and 
transplant services, requires a large workforce 
with adequate geographical coverage to meet 
the growing healthcare needs of patients with 
CKD.2 5 7 8 However, recent surveys from the 
Key questions
What is already known?
 ► Many countries in developing economies, especial-
ly in Latin America, Africa and parts of Asia, have a 
scarcity of all cadres of healthcare workers.
 ► There is a scarcity of nephrologists in many coun-
tries in the world; however, the extent of this scarcity 
has not been previously fully quantified.
What are the new findings?
 ► Our data show a varying scarcity of workforce in 
nephrology across all sectors (physicians, surgeons, 
nurses, technicians) in different parts of the world.
 ► There is a very low nephrology trainee density in 
mainly developing world regions which further im-
pacts on density of nephrologists.
What do the new findings imply?
 ► A demonstration of critical shortages in workforce 
capacity to care for patients with kidney failure 
across world countries and regions.
 ► The need for national and international policies to 
build a workforce capacity that can effectively ad-
dress the growing burden of kidney failure and de-
liver optimal care.  on M
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first iteration of the International Society of Nephrology 
Global Kidney Health Atlas (ISN- GKHA) revealed a global 
shortage of nephrologists and other healthcare providers 
essential for kidney disease care, with a much greater 
disparity reported in lower income countries.9 The 
nephrology workforce is predicted to further decrease in 
size and capacity over the next decade, which will further 
exacerbate current demand for kidney disease care.10
The second iteration of the ISN- GKHA was a multina-
tional, cross- sectional survey to assess international vari-
ability in the capacity for kidney failure care. One aim 
of the survey was to assess the current global workforce 
capacity for kidney failure care and identify areas with 
healthcare provider shortages. This is the first study 
to provide data regarding the availability of not only 
nephrologists and nephrology trainees, but also other 
healthcare professionals involved in kidney failure care 
worldwide.
METHODS
The ISN- GKHA is a project targeted at monitoring and 
evaluating global capacity for kidney care that combines 
desk research with an international survey of key stake-
holders. The full methodology for the second iteration 
of the ISN- GKHA has been published elsewhere,11–13 as 
have details about the development and validation of the 
survey.13 14 Two iterations of the survey were conducted 
in 2016 and 2018.11 14 Here, we report responses to items 
from the second survey conducted in 2018 related to 
workforce capacity for kidney failure care.
Desk research
Desk research efforts involved a broad literature review 
in April 2020 of national health systems associated with 
health workforce to determine the density of physicians, 
surgeons, nursing personnel and pharmacists in indi-
vidual countries. Data sources included The World Fact-
book from the Central Intelligence Agency (CIA)15 and 
the Global Health Observatory Data Repository from the 
WHO.16–18
Survey data
The ISN- GKHA questionnaire was designed to assess 
national and regional profiles for readiness, capacity 
and responsiveness to kidney failure, including ques-
tions about the availability of nephrologists, nephrology 
trainees and other healthcare providers essential for 
kidney failure care delivery. A non- probability, purposive 
sampling approach was used to identify survey respond-
ents. National and regional nephrology leaders affiliated 
with the ISN identified key stakeholders, including repre-
sentatives of national nephrology societies, policymakers, 
patient organisations, foundations and other advocacy 
groups. Key stakeholders were sent invitations to partic-
ipate in the survey through a link to the survey’s online 
portal, an electronic questionnaire via REDCap Cloud 
( www. redcapcloud. com). Three key opinion leaders 
from each country were invited to complete the survey: a 
nephrology society leader, a leader of a consumer repre-
sentative organisation and a policymaker.
The survey was conducted from July to September 2018; 
during this period, intensive follow- up was conducted by 
email and phone with ISN regional and national leaders 
to ensure complete and timely responses. Regional and 
national project leaders were identified through interna-
tional contacts, collaborators, ISN leaders and the ISN’s 
10 Regional Boards (Africa, Eastern and Central Europe, 
Latin America, the Middle East, North America and the 
Caribbean, North and East Asia, Oceania and Southeast 
Asia, the Newly Independent States (NIS) and Russia, 
South Asia, and Western Europe). The ISN regions are 
based on geographical proximity of countries that enable 
the ISN to effectively engage in advocacy and implement 
training and educational programmes in those areas. 
For instance, although Mexico is part of North America, 
it is part of the ISN’s Latin American region (https://
www. theisn. org/ about- isn/ regions). Each project leader 
was responsible for: (a) organising and following up on 
responses from each region and country; (b) serving as 
a liaison between the steering committee, the ISN and 
regional/national stakeholders; (c) providing access 
to additional data sources and contacts for surveys; (d) 
identifying or serving as an opinion leader on the project 
for the region/country; and (e) identifying or serving as 
a resource person to vet and review regional/national 
data.
Data handling and statistical analysis
For the survey data, after responses to the French and 
Spanish versions of the survey were translated into 
English by certified translators, data were extracted from 
all individual questionnaires and cleaned using Microsoft 
Excel. Responses were merged into a single file to create 
the global database. ISN regional leaders were consulted 
to ensure that the collected data were consistent with 
their understandings and were of high quality. Any major 
inconsistencies in responses at the country level were 
addressed with the stakeholders involved with the survey 
and clarified by ISN regional leaders when necessary. 
Using country as the unit of analysis, we imported the 
data into Stata V.15 software (Stata Corporation, 2017) 
and analysed it using a well- validated framework devel-
oped by the WHO: Assessing National Capacity for the 
Prevention and Control of Non- Communicable Diseases. 
We validated our results by triangulating the findings 
with academic research and grey literature, including 
government reports. The responses for survey items were 
summarised using descriptive statistics to report absolute 
counts and percentages. The density of each category 
of healthcare provider, including physicians, nursing 
personnel, surgeons, pharmacists, nephrologists and 
nephrology trainees, was calculated as the total number 
of healthcare provider divided by the country’s total 
population. Country population was obtained from the 
World Factbook of the CIA.15 Data were reported using 
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median (IQR) and results were stratified by ISN region 
and World Bank income group.
Patient and public involvement
Patients were not involved in our study. Members of the 
global nephrology community participated in this survey.
RESULTS
Availability (regional densities) of healthcare providers
Data from 196 countries were evaluated to assess the 
regional densities of physicians, nursing personnel, phar-
macists and surgeons. All the data in this section are 
presented as number per 10 000 population. The global 
median density of physicians was 14.8 (IQR 3.6–27.9), 
with the highest densities in Western Europe (38.3), 
the NIS and Russia (30.1), Eastern and Central Europe 
(28.7), North America (25.1), and North and East Asia 
(23.9). Densities of physicians in the Middle East (19.7) 
and Latin America and the Caribbean (14.5) were close 
to the global median. The lowest densities of physi-
cians were in Oceania and Southeast Asia (8.2), South 
Asia (7.2) and Africa (1.4). A direct relationship existed 
between physician density and World Bank income 
group (high income: 30.3; upper- middle income: 14.5; 
lower- middle income: 5.2; low- income: 0.9) (figure 1). 
Nursing personnel had the highest median global density 
compared with other healthcare professionals (29.4, IQR 
10.9–60.9). However, there was significant variability in 
the density of nursing personnel across ISN regions, 
with the highest density in Western Europe (107.9) and 
the lowest density in Africa (6.7) (figure 1). The global 
median density of pharmacists was 2.3 (IQR 0.4–6.8). 
High- income countries had the highest density of phar-
macists (7.2), followed by upper- middle- income coun-
tries (2.8), lower- middle- income countries (0.8) and 
low- income countries (0.1) (figure 1). Among all health-
care professionals, the global density of surgeons was the 
lowest, at 0.8 (IQR 0.1–3.0) (figure 1).
Current density of nephrologists across countries and regions
Representatives from 160 countries (88%) representing 
98% of the world’s population responded to survey 
questions about nephrologist density (online supple-
mental table S1). Overall, the global median number 
of nephrologists per million population (pmp) was 9.9 
(IQR 1.2–22.7). The data revealed significant regional 
variability in the density of nephrologists (table 1). The 
regions with the highest nephrologist densities were 
Western Europe (24.4 pmp) and Eastern and Central 
Europe (25.6 pmp), followed by North and East Asia 
(19.5 pmp), North America (18.1 pmp), and the NIS 
and Russia (14.4 pmp). Nephrologist density was close 
to the global median in two regions (Latin America and 
the Caribbean: 9.8 pmp; the Middle East: 8.1 pmp), and 
below the global median in three regions (Oceania and 
Southeast Asia: 5.7 pmp; South Asia: 1.2 pmp; Africa: 0.6 
pmp). Nephrologist density was directly associated with 
World Bank income group and varied widely, ranging 
from 23.2 pmp in high- income countries to 10.8 pmp in 
upper- middle, 1.6 in lower- middle and 0.2 pmp in low- 
income countries (table 1).
Current density of nephrology trainees across countries and 
regions
Representatives from 144 countries (79%) responded to 
survey questions regarding nephrology trainee density. 
The global median density for nephrology trainees was 
1.4 pmp (IQR 0.4–3.7). Relative to the density of neph-
rologists, the data showed less regional variability in the 
density of nephrology trainees, which ranges from 5.7 
pmp in Western Europe to 0.0 pmp in North America, 
where the absolute number of trainees was 637 (table 1). 
Of the eight countries in North America, five reported 
that they currently had no nephrology trainees. Three 
countries, Canada, the USA, and St. Kitts and Nevis, 
reported having nephrology trainees. The density of 
nephrology trainees was lower than the global median in 
Figure 1 Density of healthcare providers (per 10 000 population) (regional data for physicians are presented in ascending 
order (median and IQR)). Density of physicians, nursing personnel, pharmacists and surgeons, calculated by taking the total 
number of physicians, nursing personnel, pharmacists and surgeons reported in each country, respectively, and dividing it by 
each country’s population, grouped by ISN region and World Bank income group. Data from: The World Factbook from the 
Central Intelligence Agency15 and the Global Health Observatory Data Repository from the WHO.16–18 ISN, International Society 
of Nephrology; NIS, Newly Independent States.
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Oceania and Southeast Asia (1.1 pmp), Africa (0.4 pmp), 
South Asia (0.3 pmp) and North America (2.8 pmp).
Survey response rate and primary responsibility for kidney 
failure care
Among the 182 countries invited to participate in the 
2018 survey, representatives responded from 160 (88%) 
countries (online supplemental table S1). The data 
revealed significant variations across countries and 
regions in healthcare worker distribution, responsibili-
ties and shortages (tables 2 and 3). Nephrologists were 
primarily responsible for providing care to patients with 
kidney failure in 92% of countries. Primary healthcare 
providers and nurse practitioners or nurses with special-
ised training were responsible for kidney failure care in 
22% and 15% of countries, respectively. Multidisciplinary 
teams provided kidney failure healthcare in only 19% 
of countries, and health officers and extension workers 
provided kidney failure care in just 1% of countries 
(table 2).
Current capacity of health professionals required for kidney 
failure care
In addition to the shortage of nephrologists reported by 
70% of countries surveyed, more than half of countries 
reported shortages of other healthcare professionals 
essential for kidney failure care. Relative to other World 
Bank income groups, a greater proportion of low- income 
countries reported shortages of all types of kidney failure 
healthcare providers (table 3). With regard to non- 
physician kidney failure healthcare providers, 71% of 
upper- middle- income countries reported a shortage of 
vascular access coordinators, 20% reported a shortage of 
laboratory technicians, and just over half reported short-
ages of transplant coordinators (61%), dialysis nurses 
(56%), dialysis technicians (54%), and counsellors and 
psychologists (54%) (table 3). Overall, a lower propor-
tion of high- income countries reported shortages in the 
kidney failure workforce relative to countries in the other 
World Bank income groups. Although 44% of high- 
income countries reported a shortage of dialysis nurses, 
only 19% reported a shortage of dialysis technicians. Just 
over one- third of high- income countries reported short-
ages of vascular access coordinators (39%), and counsel-
lors and psychologists (37%) (table 3).
DISCUSSION
Our results confirm initial findings from the baseline 
survey for the GKHA regarding insufficient workforce 
capacity to provide kidney care.9 There was significant 
variability in the density of the healthcare workforce 
for all areas of medicine among countries and income 
groups, with the highest densities of physicians, nursing 
Table 1 Global distribution of the nephrology workforce, per million population (pmp)
Category
Nephrologist density Nephrology trainee density
Total no of 
respondent 
countries Median IQR
Total no of 
respondent 
countries Median IQR
Overall 152 9.95 (1.23–22.72) 144 1.42 (0.35–3.70)
ISN region
  Africa 39 0.62 (0.24–1.56) 35 0.36 (0.06–0.92)
  Eastern and Central Europe 19 25.63 (15.54–36.73) 19 3.26 (1.56–4.42)
  Latin America and the Caribbean 18 9.76 (8.73–19.73) 18 1.37 (0.84–3.18)
  Middle East 11 8.08 (4.97–15.87) 11 1.82 (0.72–2.86)
  NIS and Russia 8 14.41 (6.62–22.33) 7 1.60 (0.46–3.25)
  North America 9 18.13 (15.33–29.46) 8 0.00* (0.00–1.74)
  North and East Asia 7 19.45 (9.67–54.60) 7 3.22 (1.94–5.94)
  Oceania and Southeast Asia 14 5.66 (1.08–16.59) 15 1.08 (0.30–4.51)
  South Asia 7 1.15 (0.63–1.39) 6 0.29 (0.15–0.62)
  Western Europe 20 24.36 (18.07–29.91) 18 5.80 (3.73–8.03)
World Bank income level
  Low 21 0.24 (0.17–0.48) 17 0.11 (0.00–0.48)
  Lower- middle 35 1.58 (0.88–5.67) 36 0.57 (0.21–1.60)
  Upper- middle 40 10.81 (5.08–17.03) 37 1.19 (0.77–2.60)
  High 56 23.15 (16.68–30.91) 54 3.83 (1.81–7.30)
Density of nephrologists and nephrology trainees calculated by taking the total number of nephrologists or nephrology trainees provided by 
each country and dividing it by each country’s population, grouped by ISN region and World Bank income group.
*Although the median number is 0 for this region, the average number of nephrology trainees is 2.8 pmp.
ISN, International Society of Nephrology; NIS, Newly Independent States.
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personnel, pharmacists and surgeons in high- income 
countries, and the lowest densities in low- income coun-
tries. The density of nursing personnel was higher than 
the densities of physicians, surgeons, and pharmacists 
across countries and income groups. Most of the coun-
tries surveyed reported that nephrologists were primarily 
responsible for delivering kidney failure care. In terms of 
distribution, the density of nephrologists in high- income 
countries is over 60 times that in low- income countries, 
and the majority of low- income countries reported short-
ages of other key healthcare professionals involved in 
kidney care. For instance, the availability of pharmacists, 
surgeons, and nursing personnel is 70- fold, 350- fold and 
16- fold higher, respectively, in high- income countries 
compared with low- income countries. These data high-
light the need for strategies to increase the global neph-
rology workforce, especially in low- income countries.
In kidney failure management, an effective workforce 
is an essential component of optimal care delivery.19–22 
Several considerations should be taken into account to 
accurately interpret data pertaining to the nephrology 
workforce in diverse global settings.23–26 The substan-
tial between- country variation in the organisation of 
specialised nephrology care is an important factor to be 
considered when interpreting our findings. For instance, 
in some countries, nephrologists provide care for the 
entire spectrum of kidney conditions from early CKD 
to kidney failure, whereas in other countries, nephrol-
ogists only treat patients with established kidney failure 
and provide more specialised care (ie, dialysis or trans-
plant services). Task shifting, which involves training 
primary care providers, nurses or other professionals to 
provide kidney failure care with remote guidance from 
nephrologists and/or support from standard algorithms, 
may help improve capacity to deliver high- quality kidney 
failure care in countries with limited nephrologist avail-
ability.23 25 26
While the densities reported in our survey do not 
reflect factors such as burden of kidney failure, more 
nephrologists are needed in low- income countries. A 
number of factors have been cited as driving shortages in 
the nephrology workforce across countries and regions 
with significant variations across countries,21 27 including 
an ageing workforce, declining interest in nephrology 
among trainees, lack of exposure to nephrology among 
students and residents, rising costs of medical educa-
tion and specialist training, inflexible work schedules, 
erosion of nephrology practice scope by other specialists, 















Overall 157 144 (92) 34 (22) 23 (15) 30 (19) 2 (1) 3 (2)
ISN region
  Africa 41 32 (78) 12 (29) 4 (10) 7 (17) 0 (0) 1 (2)
  Eastern and Central 
Europe
19 19 (100) 4 (21) 0 (0) 1 (5) 0 (0) 0 (0)
  Latin America and the 
Caribbean
18 18 (100) 4 (22) 3 (17) 5 (28) 0 (0) 0 (0)
  Middle East 11 11 (100) 1 (9) 4 (36) 4 (36) 0 (0) 0 (0)
  NIS and Russia 9 9 (100) 2 (22) 0 (0) 0 (0) 1 (11) 0 (0)
  North America 9 8 (89) 2 (22) 2 (22) 3 (33) 0 (0) 0 (0)
  North and East Asia 7 7 (100) 0 (0) 3 (43) 2 (29) 0 (0) 0 (0)
  Oceania and Southeast 
Asia
15 14 (93) 5 (33) 5 (33) 5 (33) 1 (7) 1 (7)
  South Asia 7 5 (71) 2 (29) 0 (0) 2 (29) 0 (0) 1 (14)
  Western Europe 21 21 (100) 2 (10) 2 (10) 1 (5) 0 (0) 0 (0)
World Bank income level
  Low 22 16 (73) 9 (41) 1 (5) 2 (9) 0 (0) 1 (5)
  Lower- middle 37 33 (89) 11 (30) 4 (11) 6 (16) 2 (5) 1 (3)
  Upper- middle 41 39 (95) 8 (20) 6 (15) 11 (27) 0 (0) 1 (2)
  High 57 56 (98) 6 (11) 12 (21) 11 (19) 0 (0) 0 (0)
Number of countries that reported the healthcare providers primarily responsible for kidney failure clinical care, grouped by ISN region 
and World Bank income group. Percentages calculated as the number of responding countries divided by the total number of responding 
countries.
ISN, International Society of Nephrology; n, number of participating countries; NIS, Newly Independent States.
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inadequate training, reduced focus on scholarship and 
academic training, increased demand to meet quality 
of care standards and the development of new kidney 
failure care delivery models.27
This study provides data regarding the global avail-
ability of not only nephrologists and nephrology trainees, 
but also other healthcare professionals involved in 
kidney failure care. More than half of countries surveyed 
reported shortages in nephrologists, interventional 
radiologists for haemodialysis (HD) access and perito-
neal dialysis (PD) access, surgeons for transplantation, 
HD access and PD access, as well as vascular access and 
transplant coordinators, counsellors or psychologists, 
dialysis nurses, and dietitians. Overall, these findings are 
consistent with data from the Global Burden of Diseases, 
Injuries and Risk Factors Study 2017, which reported 
shortages of physicians, nurses or midwives, and phar-
macists in almost 50% of countries in all areas of medi-
cine, not just nephrology. Similar to the findings of our 
study, the greatest shortages of healthcare workers were 
reported in sub- Saharan Africa, Southeast Asia, South 
Asia and Oceania.28 Increasing the number of healthcare 
professionals in these regions and creating multidisci-
plinary teams are important, considering the complexity 
of care for patients with kidney failure. Furthermore, 
distributing the workload for kidney failure care across 
multiple providers would increase overall care capacity, 
which is particularly important in areas with significant 
nephrologist shortages. Another important component 
of kidney failure care is conservative kidney care, which is 
widely used as a method of providing non- dialysis medical 
management for patients with kidney failure.29–31 Symp-
toms, quality of life, psychological, social and family 
support are essential for comprehensive conservative 
care. This study demonstrated shortages in counsellors/
psychologists, who are essential healthcare professionals 
for conservative kidney care. Shortages were greater in 
low- income and lower- middle- income countries. In coun-
tries where kidney replacement therapy was limited or 
self- funded, conservative kidney care was an important 
alternative treatment strategy.
Specifically, country- level data regarding the distri-
bution of kidney failure care and professional respon-
sibilities can be used to tailor policies and ensure the 
effective utilisation of resources to address specific issues. 
These data can be used to guide workforce develop-
ment and policy change initiatives across countries and 
regions. In order to create effective policies to expand 
local nephrology care, strategies will need to be tailored 
to each regional healthcare system based on available 
resources. For instance, in upper- middle- income coun-
tries, there are relatively fewer surgeons and interven-
tional radiologists available for PD access compared with 
the number available for HD access. Resources can be 
used to increase the availability of physicians who can 
provide PD access, which may involve training existing 
HD surgeons and interventional radiologists to perform 
PD catheter insertions or expanding the scope of other 
healthcare professionals, such as general physicians and/
or community health officers (particularly in low- income 
countries), to perform PD catheter insertions. For this 
to be carried out effectively, nephrology care should be 
centralised by implementing public health strategies and 
creating national nephrology agencies to implement 
public policies and strategies to expand the nephrology 
workforce.31–34
This study provides international agencies, such as 
the ISN, with data regarding international variability 
in workforce shortages. Only 41% of low- income coun-
tries had nephrology training programmes.9 The ISN 
sponsors medical trainees from developing countries to 
pursue fellowship training in nephrology with the goal 
of increasing the number of trainees and physicians in 
lower income countries,35 in addition to many other 
initiatives that aim to increase the nephrology workforce 
in developing countries.36–40 However, this study revealed 
a global shortage of not only nephrologists, but all health-
care professionals involved in kidney care, particularly 
in low- income countries. Therefore, expanding interna-
tional initiatives to provide funding to train other health-
care professionals, and facilitating the redistribution of 
nephrology care to nurses and primary care physicians, 
may be a more time- effective and cost- effective method of 
addressing the global nephrology workforce shortage.41 42 
Healthcare training programmes will need to be modified 
in order to change professional scopes of practice and 
develop new competencies. For instance, this may involve 
nephrologists training to perform kidney ultrasounds, or 
nurses training to manage outpatient CKD care. This is 
particularly important in low- income countries, where 
the overall nephrology workforce is sparse, nephrology 
training programmes are limited, and the rates of CKD 
and kidney failure continue to rise.1–3 9 Several strategies 
have been proposed for lower- middle- income countries 
regarding expanding their kidney failure workforces. 
These include: government provision of funding and 
infrastructure for kidney failure care; forming public–
private partnerships with industry for kidney failure work-
force training; using international nephrology societies 
to train, fund and expand the kidney failure workforce; 
creating partnerships with academic medical centres; 
and using web- based teaching programmes to train physi-
cians, nurses and technicians.43 While these strategies are 
useful, it has to be acknowledged that several competing 
public values, social and political dynamics as well as 
resource constraints may influence the achievement of 
the desired workforce goals for equitable kidney care 
across countries.
Study limitations
Our study has some limitations worth noting. First, the 
lack of standardised frameworks or benchmarks to assess 
workforce adequacy limits our ability to draw firm conclu-
sions across the diverse settings targeted by our survey. 
Second, like all questionnaires, our survey introduced the 
potential for subjectivity (ie, social desirability bias) and 
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was highly dependent on respondents’ knowledge and 
perceptions. Although the survey questions were assessed 
for face validity, there was a baseline presumption that 
respondents accurately reported the status of the kidney 
failure workforce in each country. We strove to overcome 
this limitation by working closely with the ISN’s regional 
boards to select respondents with a range of kidney care 
expertise to ensure adequate regional representation, 
and by corroborating findings with regional leaders and 
secondary data sources.
CONCLUSION
Overall, nephrologists were primarily responsible for 
kidney failure care across all regions and countries of the 
world. Important gaps in workforce capacity exist, particu-
larly in low- income and lower- middle- income countries. 
Efforts to increase workforce capacity in resource- limited 
countries are required to ensure high quality of care for 
patients with kidney failure.
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